Manulife PRS

The above information has not been reviewed by the SC and is subject to the relevant warning, disclaimer, qualification or terms and conditions stated herein. Investors are advised to read and understand the contents of the Master Prospectus dated 3 January 2023; Master Prospectus dated 10 August 2020 and its First Supplemental Master Prospectus dated 10 August 2020 and its Second Supplemental Master Prospectus dated 27 January 2021 and its Third Supplemental Master Prospectus dated 5 April 2021 and its Fourth Supplemental Master Prospectus dated 13 September 2021 and its Fifth Supplemental Master Prospectus dated 15 September 2022; Prospectus dated 18 August 2022; Prospectus dated 16 November 2021; Prospectus dated 26 October 2021 for Manulife Global Aqua Fund; Prospectus dated 26 October 2021 and its First Supplemental Prospectus dated 26 October 2021 for Manulife Shariah India Equity Fund; Prospectus dated 30 September 2021; Prospectus dated 24 August 2021; Prospectus dated 21 June 2021 and its First Supplemental Prospectus dated 13 September 2021; Prospectus dated 2 February 2021 and its First Supplemental Prospectus dated 23 June 2021 and its Second Supplemental Prospectus dated 13 September 2021; Prospectus dated 5 January 2021 and its First Supplemental Prospectus dated 13 September 2021; Prospectus dated 29 July 2020 and its First Supplemental Prospectus dated 27 November 2020 and its Second Supplemental Prospectus dated 13 September 2021; Prospectus dated 7 October 2020 and its First Supplemental Prospectus dated 9 February 2021 and its Second Supplemental Prospectus dated 13 September 2021; Disclosure Document dated 14 February 2022 for Manulife PRS NESTEGG Series; Disclosure Document dated 14 February 2022 for Manulife Shariah PRS NESTEGG Series;  Information Memorandum dated 9 August 2021; Information Memorandum dated 11 February 2020 for Manulife Dragon Growth Fund; Information Memorandum dated 11 February 2020 and its First Supplemental Information Memorandum dated 13 September 2021 its Second Supplemental Information Memorandum dated 31 January 2022 for Manulife Asian Small Cap Equity Fund; Information Memorandum dated 11 February 2020 and its First Supplemental Information Memorandum dated 31 January 2022 for Manulife SGD Income Fund; Information Memorandum dated 11 February 2020 for Manulife Global Emerging Markets Multi-Asset Income Fund; Information Memorandum dated 11 February 2020 and its First Supplemental Information Memorandum dated 31 January 2022 for Manulife ASEAN Equity Fund; Information Memorandum dated 4 September 2019 and its First Supplemental Information Memorandum dated 18 October 2019; Master Information Memorandum dated 26 November 2019 for 2 Funds and Information Memorandum dated 3 February 2020 and its First Supplemental Information Memorandum dated 13 September 2021 and all the respective Product Highlights Sheet(s) (collectively, the “Offering Documents”), obtainable at our offices or website, before investing. The Offering Documents have been registered with the Securities Commission Malaysia (SC), however the registration with the SC does not amount to nor indicate that the SC has recommended or endorsed the product. There are risks involved with investing in unit trust funds; wholesale funds and/or Private Retirement Schemes. Some of these risks associated with investments in unit trust funds; wholesale funds and/or Private Retirement Schemes are interest rate fluctuation risk, foreign exchange or currency risk, country risk, political risk, credit risk, non-compliance risk, counterparty risk, target fund manager risk, liquidity risk and interest rate risk. For further details on the risk profile of all the funds, please refer to the Risk Factors section in the Offering Documents. The price of units and income distribution may go down as well as up. Investors should compare and consider the fees, charges and costs involved. Investors are advised to conduct own risk assessment and consult the professional advisers if in doubt on the action to be taken. Past performances are not an indication of future performances. Where a unit split/distribution is declared, investors are advised that following the issue of additional units/distribution, the NAV per unit will be reduced from the pre-unit split NAV/cum-distribution NAV to post-unit split NAV/ex-distribution NAV; and where a unit split is declared, the value of your investment in the Fund’s denominated currency will remained unchanged after the distribution of the additional units. You are advised not to solely rely upon the ratings or rankings disclosed herein in making an investment decision. The ratings or rankings disclosed herein are current; the same may change in the future.

The Manager, Manulife Investment Management (M) Berhad Registration No: 200801033087 (834424-U) (hereinafter referred to as “Manulife IM (Malaysia)”) is a wholly owned subsidiary of Manulife Holdings Berhad and holds a Capital Markets Services License for fund management, dealing in securities restricted to unit trusts, dealing in private retirement schemes and financial planning under the Capital Markets and Services Act 2007. Manulife IM (Malaysia) operates under the brand name of Manulife Investment Management which is the global wealth and asset management segment of Manulife Financial Corporation.